IgG from patients with mild or severe COVID‑19 reduces the frequency and modulates the function of peripheral mucosal-associated invariant T cells in PBMCs from healthy individuals

  • Authors:
    • Nicolle Rakanidis Machado
    • Beatriz Oliveira Fagundes
    • Iara Grigoletto Fernandes
    • Daniela Terra De Apoena Reche
    • Maria Notomi Sato
    • Jefferson Russo Victor
  • View Affiliations

  • Published online on: October 16, 2023     https://doi.org/10.3892/br.2023.1677
  • Article Number: 95
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Lower levels of peripheral mucosal‑associated invariant T (MAIT) cells have been observed in the peripheral blood of patients with severe coronavirus disease 2019 (COVID‑19). Following on from previous research into the effect of the IgG repertoire on human lymphocytes, the present study aimed to evaluate if immunoglobulin G (IgG) antibodies obtained from patients with mild or severe COVID‑19 contribute to these effects on MAIT cells. Culture experiments were performed using healthy human peripheral blood mononuclear cells (PBMCs) and different repertoires of IgG obtained from patients with COVID‑19 as a mild or severe disease and compared with mock, healthy control or therapeutic IgG conditions. The results indicate that the IgG repertoire induced during the development of mild and severe COVID‑19 has, per se, the in vitro potential to reduce the frequency of MAIT cells and the production of IFN‑γ by the MAIT cell population in PBMCs from healthy individuals. In conclusion, the results of the present study indicate that IgG in patients with severe COVID‑19 may participate in the reduction of peripheral MAIT cell frequency and hinder the antiviral activity of these cells.
View Figures
View References

Related Articles

Journal Cover

December-2023
Volume 19 Issue 6

Print ISSN: 2049-9434
Online ISSN:2049-9442

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Rakanidis Machado N, Fagundes BO, Fernandes IG, Terra De Apoena Reche D, Sato MN and Victor JR: IgG from patients with mild or severe COVID‑19 reduces the frequency and modulates the function of peripheral mucosal-associated invariant T cells in PBMCs from healthy individuals. Biomed Rep 19: 95, 2023
APA
Rakanidis Machado, N., Fagundes, B.O., Fernandes, I.G., Terra De Apoena Reche, D., Sato, M.N., & Victor, J.R. (2023). IgG from patients with mild or severe COVID‑19 reduces the frequency and modulates the function of peripheral mucosal-associated invariant T cells in PBMCs from healthy individuals. Biomedical Reports, 19, 95. https://doi.org/10.3892/br.2023.1677
MLA
Rakanidis Machado, N., Fagundes, B. O., Fernandes, I. G., Terra De Apoena Reche, D., Sato, M. N., Victor, J. R."IgG from patients with mild or severe COVID‑19 reduces the frequency and modulates the function of peripheral mucosal-associated invariant T cells in PBMCs from healthy individuals". Biomedical Reports 19.6 (2023): 95.
Chicago
Rakanidis Machado, N., Fagundes, B. O., Fernandes, I. G., Terra De Apoena Reche, D., Sato, M. N., Victor, J. R."IgG from patients with mild or severe COVID‑19 reduces the frequency and modulates the function of peripheral mucosal-associated invariant T cells in PBMCs from healthy individuals". Biomedical Reports 19, no. 6 (2023): 95. https://doi.org/10.3892/br.2023.1677